United States · Bill · HR
H.R. 4876 (114th)
Medicare Prescription Drug Abuse Prevention Act of 2016
Introduced
23 March 2016
Last action
29 March 2016 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Meehan, Patrick [R-PA-7], Rep. Neal, Richard E. [D-MA-1], Rep. Reed, Tom [R-NY-23], Rep. Tiberi, Patrick J. [R-OH-12]
Subjects
Healthcare
Source updated
20 January 2026
Summary
Medicare Prescription Drug Abuse Prevention Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to: (1) authorize a Medicare prescription drug plan (PDP) sponsor to establish a drug management program under which the PDP sponsor may limit an at-risk beneficiary's access to coverage for frequently abused drugs to include only those drugs that are prescribed by selected prescribers and dispensed by selected pharmacies; and (2) require a PDP sponsor to have in place a utilization management tool to prevent drug abuse. With respect to a drug management program, a PDP sponsor must: (1) provide specified notice to a beneficiary who has been identified by the Centers for Medicare & Medicaid (CMS) as "at-risk" and consequently enrolled in the program; and (2) in selecting prescribers and dispensers, ensure that the beneficiary continues to have reasonable access to drugs. These determinations shall be subject to expedited reconsideration and appeal. A PDP sponsor must review and consider an at-risk beneficiary's preferences regarding prescriber and pharmacy selection. Certain individuals, including those receiving hospice care or residing in a long-term care facility, are exempted from enrollment in a drug management program. CMS must, for purposes of quality or performance assessments, review and consider complaints received from at-risk beneficiaries regarding lack of access due to their enrollment in a drug management program. In addition, CMS must establish rules and procedures requiring a PDP sponsor to provide specified program data.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
23 March 2016
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
23 March 2016
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
23 March 2016
Introduced
Introduced in House
Source: IntroReferral
23 March 2016
Introduced
Introduced in House
Source: IntroReferral
25 March 2016
Referred
Referred to the Subcommittee on Health.
Source: Committee
29 March 2016
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 23 March 2016 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 23 March 2016
Introduced in House (PDF)
Introduced in House · EN · 23 March 2016
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 23 March 2016
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Meehan, Patrick [R-PA-7] · R · Sponsor
- Rep. Neal, Richard E. [D-MA-1] · D · Sponsor
- Rep. Reed, Tom [R-NY-23] · R · Cosponsor
- Rep. Tiberi, Patrick J. [R-OH-12] · R · Cosponsor
- · hswm00 · Standing
- · hsif00 · Standing
Related records
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/114th-congress/house-bill/4876
- Open data entity: https://api.congress.gov/v3/bill/114/hr/4876
- us · 114-hr-4876 · source updated 20 January 2026